FDA Approvals Roundup: Kloxxado, Farxiga, Ferriprox
The Pharma Data
MAY 5, 2021
It also provided supporting pharmacokinetic data demonstrating the opioid antagonist’s safety and efficacy. . A total of 197 patients in the study arm had at least one of the composite endpoint events, compared with 312 patients in the placebo arm. New indications.
Let's personalize your content